Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$4,153,569
+$344,015 QoQ
Shares Held
16,506
-5.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.55%
of 13F equity value
Holder Rank
#1,430
of 4,153 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TFR Capital, LLC. holds $14,292,120 across 7 Drug Manufacturers - General names. ABBV ranks #2 (29.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,709 | $5,648,116 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
16,506 | $4,153,569 | |
| 3 | JNJ |
Johnson & Johnson
|
10,871 | $2,760,907 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,757 | $868,274 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,423 | $306,121 | |
| 6 | AMGN |
Amgen Inc
|
820 | $296,938 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,481 | $258,195 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,153,569 | 16,506 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $3,809,554 | 17,516 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $3,910,834 | 17,116 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $3,797,024 | 16,399 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $2,890,845 | 15,574 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $3,189,313 | 15,222 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $2,342,796 | 13,184 | Shares | Sole | 2025-03-06 | |
| No filing history on record for this holder in this stock. | ||||||